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Small conductance Ca2+‐sensitive K+
channelWe tested if small conductance, Ca2+‐sensitive K+ channels (SKCa) precondition hearts against ischemia reper-
fusion (IR) injury by improving mitochondrial (m) bioenergetics, if O2‐derived free radicals are required to
initiate protection via SKCa channels, and, importantly, if SKCa channels are present in cardiac cell innermitochon-
drial membrane (IMM). NADH and FAD, superoxide (O2
•−), and m[Ca2+] were measured in guinea pig isolated
hearts by ﬂuorescence spectrophotometry. SKCa and IKCa channel opener DCEBIO (DCEB) was given for 10 min
and ended 20 min before IR. Either TBAP, a dismutator of O2•−, NS8593, an antagonist of SKCa isoforms, or
other KCa and KATP channel antagonists, were given before DCEB and before ischemia. DCEB treatment resulted
in a 2-fold increase in LV pressure on reperfusion and a 2.5 fold decrease in infarct size vs. non-treated hearts as-
sociatedwith reduced O2•− andm[Ca2+], andmore normalized NADH and FAD during IR. Only NS8593 and TBAP
antagonized protection by DCEB. Localization of SKCa channels to mitochondria and IMM was evidenced by
a) identiﬁcation of puriﬁed mSKCa protein by Western blotting, immuno-histochemical staining, confocal mi-
croscopy, and immuno-gold electronmicroscopy, b) 2-D gel electrophoresis andmass spectroscopy of IMMpro-
tein, c) [Ca2+]‐dependence of mSKCa channels in planar lipid bilayers, and d) matrix K+ inﬂux induced by DCEB
and blocked by SKCa antagonist UCL1684. This study shows that 1) SKCa channels are located and functional
in IMM, 2) mSKCa channel opening by DCEB leads to protection that is O2•− dependent, and 3) protection by
DCEB is evident beginning during ischemia.
© 2012 Elsevier B.V. All rights reserved.1. Introduction
Depressed mitochondrial (m) bioenergetics, excess reactive
oxygen species (ROS) generation, and mCa2+ loading are major fac-
tors underlying ischemia and reperfusion (IR) injury [1]. Prophylactic
measures targeted in part to mitochondria that reduce cardiac IR inju-
ry [2,3] include ischemic preconditioning (IPC, i.e., brief pulses of
ischemia and reperfusion before longer ischemia) and pharmacologiconductance Ca2+‐sensitive K+
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rights reserved.pre-conditioning (PPC), i.e., cardiac protection elicited some time
after the drug is washed out. PPC is theoretically a better approach
because it does not require the heart to ﬁrst undergo brief ischemia.
We reported previously that activation of a large (big) conductance
Ca2+‐sensitive K+ channel (mBKCa), which may be located in the
cardiac myocyte inner mitochondrial membrane (IMM), can induce
PPC [4]. The BKCa channel has not been found in the cardiac myocyte
plasma membrane, but we have shown that a BKCa channel opener,
NS1619, has biphasic effects on mitochondrial respiration, membrane
potential (ΔΨm), and superoxide radical (O2•−) production in isolated
mitochondria [5,6]. This suggested that opening of other mitochon-
drial K+ channels could also elicit PPC.
There are other KCa channels of intermediate or small conductances
identiﬁed in non-cardiac cells [7–10] that are membrane bound,
calmodulin (CaM)‐dependent and gated by Ca2+ and other factors.
These channels have smaller unit conductances of 3–30 (small, SKCa)
and 20–90 (intermediate IKCa) pS [11]. The opening of SKCa channels
is initiated by Ca2+ binding to calmodulin at the C terminus of the chan-
nel [12,13]. KCa2.3 is one of the known isoforms of SKCa channels that
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a potent, tonic hyperpolarization that reduced vascular smooth muscle
tone [14]. Moreover, there is evidence for the KCa2.2 isoform in rat and
human hearts using Western blot analysis and reverse transcription‐
polymerase chain reaction [15]. Clones of the channel from atria and
ventricles showedmuch greater expression in atria compared to ventri-
cles, and electrophysiological recordings exhibited much greater atrial
than ventricular sensitivity to AP repolarization by apamin, a selective
SKCa antagonist [15,16].
We postulated that activation of SKCa channels induces a
preconditioning effect similar to that elicited by a BKCa (KCa1.1,
maxi-K) opener, and that this effect is mediated via channels located
in the IMM, i.e., they promote K+ entry into the mitochondrial matrix.
We tested if the KCa3.1 (IKCa1) [7,9,17] and KCa2.2 and KCa2.3 (SKCa)
[18–21] opener DCEBIO (DCEB), given transiently before ischemia,
elicits PPC in a manner similar to that of the mBKCa channel opener
NS1619 [4]. We speciﬁcally examined the role of DCEB in attenuating
the deleterious effects of IR injury on mitochondrial bioenergetics by
near continuous measurement of m[Ca2+], NADH and FAD, and O2•−
in isolated perfused hearts. We infused NS8593 to antagonize SKCa
channel opening [22,23], and several other K+ channel blockers to
rule out effects of DCEB on other putative mK+ channels, i.e., IKCa
(KCa3.1) BKCa, and KATP channels. Because the protective effects of pu-
tative KATP [24] and BKCa [4] channel openers can be abolished by ROS
scavengers, we similarly bracketed DCEB with a matrix targeted
dismutator of O2•− to assess the role of SKCa channel opening on O2•−
production, presumably by mitochondrial respiratory complexes.
We used several approaches to furnish solid evidence for the pres-
ence and functionality of SKCa channel proteins in the IMM of guinea
pig isolated cardiac mitochondria, and in isolated IMM.
2. Materials and methods
2.1. Isolated heart model
The investigation conformed to the Guide for the Care and Use of
Laboratory Animals (NIH Publication 85‐23, revised 1996). Guinea
pig hearts were isolated and prepared as described in detail
[4,25–31] with care to minimize IPC. These were pre-oxygenation,
maintained respiration after anesthesia with ketamine (50 mg/kg),
and immediate aortic perfusion with cold perfusate. Hearts were
instrumented with a saline ﬁlled balloon and transducer to measure
left ventricular pressure (LVP) and an aortic ﬂow probe to measure
coronary ﬂow (CF). Heart rate and rhythm were measured via atrial
and ventricular electrodes. Hearts were perfused at constant pressure
with modiﬁed Krebs-Ringer's solution at 37 °C. Heart rate (HR) and
rhythm, myocardial function (isovolumetric LVP), coronary ﬂow and
venous pO2 were measured continuously. %O2 extraction, myocardial
O2 consumption (MVO2) and cardiac efﬁciency (HR·LVP/MVO2) were
calculated. At 120 min reperfusion, hearts not isolated for mitochondria
were stained with 2,3,5-triphenyltetrazolium chloride (TTC) and infarct
size was determined as a percentage of ventricular heart weight
[4,26,30].
2.2. Cardiac ﬂuorescence measurements
Either m[Ca2+], NADH and FAD, or ROS (principally O2•−) was
measured near continuously or intermittently in the heart using one
of four excitation (λex) and emission (λem) ﬂuorescence spectra
described below. NADH and FAD were measured in the same heart;
m[Ca2+] and ROS were measured in different subsets of hearts. A
trifurcated ﬁber optic probe (3.8 mm2 per bundle) was placed against
the LV to excite and to record light signals at speciﬁc λ's using
spectrophotoﬂuorometers (SLMAmico-Bowman and Photon Technology
International). The incident polychromic light was ﬁltered at 350 or
490 nm and recorded at 390/450 or 540 nm, respectively, to measureNADH [25,28,30,32,33] and FAD [30,32] tissue autoﬂuorescence. Alterna-
tively, hearts assigned to measure Ca2+, were loaded with 6 μM indo 1
AM for 30 min followed by washout of residual dye for 20 min. Ca2+
transients were recorded at the same wavelengths as for NADH.
Then heartswere perfusedwithMnCl2 to quench cytosolic Ca2+ to reveal
non-cytosolic [Ca2+], mostly [mCa2+] [25,29,33]. In other hearts,
as reported earlier [4,26,27,31,33,34], dihydroethidium (10 μM, DHE),
which is used tomeasure intracellular superoxide (O2•−) level, was loaded
for 30 min and washed out of residual dye for 20 min. The LV wall was
excited with light (λex 540 nm; λem 590 nm) to measure a ﬂuorescence
signal that is primarily amarker of the free radical O2•− [31,35]. DHE enters
cells and is oxidized by O2•− where it is converted to the labile cation,
2-hydroxyethidium (2-HE+), which causes a red-shift in the EM light
spectrum [36,37].
Myocardial ﬂuorescence intensity was recorded in arbitrary ﬂuo-
rescence units (afu) during 35 discrete sampling periods throughout
each experiment at a sampling rate of 100 points/s (100 Hz, pulse
width 1 μs) during a 12 s triggered period for O2•− and for a 2.5 s trig-
gered period for NADH and FAD, and m[Ca2+]. For each ﬂuorescence
study, no drug alone had any effect on background autoﬂuorescence.
Signals were digitized and recorded at 200 Hz (Power LAB/16sp,
Chart and Scope version 3.6.3. AD Instruments) on G5 Macintosh
computers for later analysis using speciﬁcally designed programs
with MATLAB (MathWorks) and Microsoft Excel software. All vari-
ables were averaged over the 2.5 or 12 s sampling period.
2.3. Protocol
Hearts were infused with 3 μM DCEBIO (DCEB) for 10 min and
ended 20 min before the onset of 30 min global ischemia. DCEB is
derived from the benzimidazolone class of compounds, which are
known to stimulate chloride secretion in epithelial cells [7,8,38].
DCEB non-selectively opens KCa2.2 and 2.3 channels [7,18–21]. In
most hearts DCEB was bracketed either with 40 μM PAX (paxilline),
a blocker of BKCa channels [39], 20 μM TBAP, a chemical dismutator
of O2•− that can enter the matrix, 200 μM GLIB (glibenclamide), a
KATP channel blocker, or 100 nM TRAM (TRAM-34), an established
blocker of IKCa conductance channels [9]. TRAM was selected because
DCEB also opens IKCa channels [7,9,17,21]. PAX, TBAP, GLIB, or TRAM
was given 5 min before, during DCEB perfusion, and for 5 min after
stopping DCEB. In a separate study DCEB was bracketed with 10 μM
NS8593, a speciﬁc antagonist of SKCa channels [22,23] to compare
with a no drug IR control. Drug exposurewas discontinued 15 min be-
fore the onset of global ischemia that lasted for 120 min. NS8593
caused a transient fall in systolic (and developed) LVP and an increase
in coronary ﬂow. Additional studies (not displayed) showed that each
of these drugs, except for NS8593, given alone (without DCEB) for
20 min before ischemia elicited no appreciable effects and had no dif-
ferent effect on IR injury than the drug-free controls.
2.4. Statistical analyses
A total of 155 isolated heart experiments were divided into 7
groups, a drug-free control, and DCEB alone or plus NS8593, PAX,
TBAP, GLIB or TRAM. Functional data were recorded from 12 to 15
hearts per group. Infarct size was measured in a blinded manner in
8 hearts per group. NADH and FAD were measured in approximately
6–8 hearts per group, O2•− in 5–7 hearts per group, and m[Ca2+] in
6–8 hearts per group. Because functional studies showed trends that
PAX, GLIB, or TRAM did not block protective effects of DCEB, only
four groups were compared in NADH and FAD experiments and
three groups were compared in O2•− and m[Ca2+] experiments. All
data were expressed as means±standard error of means. Appropri-
ate comparisons were made among groups that differed by a variable
at a given condition or time, and within a group over time compared
to the initial control data. Statistical differences were measured across
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ences among variables were determined by two-way multiple
ANOVA for repeated measures (Statview® and CLR ANOVA® soft-
ware programs for Macintosh®); if F tests were signiﬁcant, appropri-
ate post-hoc tests (e.g., Student–Newman–Keuls, SNK) were used
to compare means. The incidence of ventricular ﬁbrillation (VF) vs.
sinus rhythm per group, and the number of VFs per heart per group,
were determined by Fisher's Exact Test. In mitochondria K+ ﬂux
experiments drug treatments were compared to control using the
same statistical tests. Mean values were considered signiﬁcant at
P values (two-tailed) b0.05.
2.5. Isolation of cardiac mitochondria and inner mitochondrial membranes
(IMMs)
Mitochondria were freshly isolated from 25 guinea pig hearts by
differential centrifugation as described previously [5,6,34,40,41].
To test mitochondrial viability and function in each preparation, the
respiratory control index (RCI, state 3/state 4) was determined under
both pyruvate (P, 10 mM), and succinate (S, 10 mM)+rotenone
(R, 4 μM) conditions. State 3 respiration was determined after adding
250 μM ADP. Intact mitochondrial preparations were discarded if the
RCI was less than 3 with succinate+R or less than 9 with pyruvate.
To isolate fraction-enriched IMMs, isolated mitochondria were
shocked osmotically by incubating in 10 mM phosphate buffer saline
(PBS) (pH 7.4) for 20 min, and then in 20% sucrose for another
15 min. The IMMswere sonicated for 30 s, 3 times, and then centrifuged
at 8000 g for 10 min. The supernatant containing sub-mitochondrial
particles was fractionated using a continuous sucrose gradient (30% to
60%) and centrifuged at 80,000 g overnight in a SW28 rotor. The IMMs
(enriched in theheavy fractions)were suspendedwith the isolationme-
dium without EGTA and centrifuged at 184,000 g for 30 min. The ﬁnal
pellet enriched IMMs were suspended in isolation medium without
EGTA and BSA and stored at−80 °C in small aliquots until use.
2.6. Enhancement of calmodulin-binding proteins from IMM
Calmodulin binds to SKCa channels so the calmodulin binding proteins
obtained from the IMMs were concentrated to enhance the sensitivity of
detection of mSKCa channels byWestern blotting and bymass spectrom-
etry. For calmodulin column chromatography (calmodulin-sepharose
beads) the IMMs (5 mg protein)were solubilized for 2 h at 4 °C inwash-
ing buffer, 200 mM KCl, 1 mM MgCl2, 200 μM CaCl2, 20 mM HEPES,
pH 7.4, and 0.5% CHAPS with protease inhibitors. After centrifugation
at 50,000 g for 30 min, the supernatant was applied to a calmodulin-
sepharose column (10 by 1.5 cm) pre-equilibrated with the solubiliza-
tion buffer containing 0.1% CHAPS. The column was washed rapidly
with 500 mL of washing buffer as above. The proteins were eluted from
the column by 2 mM EGTA in the elution buffer (200 mM KCl, 20 mM
HEPES, pH 7.4, 0.1% (w/v) CHAPS) after washing. The fractions collected
were concentrated and the proteins were separated by 2-D gel electro-
phoresis as follows.
2.7. Puriﬁcation of SKCa channel proteins from IMM by isoelectric
focusing
After isolating the IMM protein fraction (Sections 2.5 and 2.6) the
ﬁrst dimension of isoelectric focusing (IEF) during 2-D gel electro-
phoresis was done in native gel buffer on an Immobilon Drystrips
(Amersham) with pH 4–7 gradient. The antibody was targeted to
KCa2.3 (a.k.a. hSK3, KCN3, Osenses Pty, Ltd.). The second dimension
was done in a 10% Criterion® tris-SDS gel (Bio-Rad). Two identical
gels were run at the same time, with one used for transfer to nitrocel-
lulose membrane for Western blot analysis, and the other for silver
staining and visualization.2.8. IMM protein identiﬁcation using electrospray LC/MS
IMM proteins (from Sections 2.5 and 2.6) were digested with tryp-
sin and subjected to pH focusing into 10 fractions over pH 3–10 and
each fraction was directly analyzed using a NP LC/ESI mass spectrom-
eter (Finnigan™ LTQ™ Ion Trap MS, Thermo Electron Corporation) to
generate speciﬁc mass spectra typical for a given protein. The instru-
ment utilizes stepped normalized collision energy (SNCE) to improve
fragmentation efﬁciency over a wide mass range. This increases the
capacity of a linear trap and the accuracy and sensitivity of peptide
detection in the fmol range. A mass database (NCBI Entrez Pubmed
protein) was searched for matching proteins and consequently the
SKCa channel protein of interest was tentatively identiﬁed in IMM.
2.9. Puriﬁcation of intact mitochondria by Percoll gradient fractionation
To further verify localization of SKCa channel protein in an intact
mitochondria preparation, the Percoll gradient technique [42,43],
with slight modiﬁcations, was used to purify intact mitochondria
and immuno-histochemical staining was utilized to identify SKCa
channel protein. In brief, mitochondria isolated as previously described
[5,6,34,40,41] were layered over 30% Percoll (in buffer A containing
450 mM mannitol, 50 mM HEPES, 2 mM EDTA, pH adjusted to 7.4
followed by addition of 50 mg BSA), and centrifuged at 95,000 g for
30 min. The lower dense band observed at the bottom of the tube,
enriched in mitochondria, was collected using a long tip glass pipette.
Collected mitochondria (~4 mL) were resuspended in the same buffer
used to dilute Percoll, and centrifuged again at 6300 g. The resulting
pellet was suspended in the same buffer without BSA (buffer B) and
re-centrifuged at 6300 g. The mitochondrial pellet was resuspended in
a small volume (~0.3 mL) of buffer B and stored until further use.
2.10. Identiﬁcation and localization of SKCa channel protein in puriﬁed
mitochondria
Immuno-histochemical staining with an anti‐SKCa antibody and
confocal microscopy were used, in part, to verify that SKCa channel pro-
tein resides in mitochondria. Brieﬂy, mitochondria, isolated and puri-
ﬁed as described above (Section 2.9), were ﬁxed onto poly-lysine
coated coverslips. Mitochondrial structures were then ﬁxed using para-
formaldehyde and membranes were permeabilized using Triton X-100
and non-speciﬁc binding sites blocked by goat serum albumin. Cover-
slips were then incubated in solution containing anti-KCa2.2 (anti-SK2,
ETQMENYDKHVTYNAERS, Alomone Labs (1:1000 in 5% milk)) and
anti-ANT (adenine nucleotide translocase, Invitrogen) antibodies for
30 min followed by threewashes in 0.1 MPBS. Coverslips were then in-
cubated in appropriate secondary antibodies (Alexa Flour 455 and 546
respectively, Invitrogen (1:3000 in 2% milk)) for another 30 min and
were then transferred onto microscope slides and visualized using a
Leica confocal microscope (TCS SP5). Alternatively, mitochondria were
utilized for immuno-gold labeling to localize SKCa channel protein in in-
dividual mitochondria.
2.11. Localization of SKCa channel protein by immuno-gold labeling and
electron microscopy
Immuno-electron microscopy (IEM) was used to localize SKCa
protein in puriﬁed cardiac mitochondria similar to the technique
used by Douglas et al. [44] to localize BKCa channel protein in mitochon-
dria. The ﬁnal mitochondrial pellet, prepared as described above
(Section 2.9), was resuspended in 500 μL isolation buffer before centrifu-
gation at 16,000 g for 20 min. The supernatant was discarded and an EM
ﬁxative containing 0.1% glutaraldehyde+2% paraformaldehyde in 0.1 M
NaH2PO4 buffer (pH 7.4) was added. After 1 h ﬁxation at room tempera-
ture the pellet was gently detached from the tubewith a 25 G needle and
processed following the protocols of Berryman and Rodewald [45].
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3.5% sucrose and 0.5 mMCaCl2, then rinsed in 0.1 Mglycine inNaH2PO4
buffer for 1 h on ice before returning to NaH2PO4 buffer. The pellets
were cut into 1 mmcubes and thenwashed 4×15 min in 0.1 M trisma-
leate buffer+3.5% sucrose, pH 6.5, at 4 °C followed by post ﬁxation in
2% Uranyl acetate (w/v) in tris buffer, pH 6, for 2 h at 4 °C; specimens
were then given a ﬁnal rinse 2×5 min in Tris maleate buffer, pH 6.5.
The specimens were then processed by the progressive lowering-
of-temperature method into Lowicryl K4M resin and the resin was po-
lymerized by UV irradiation. Ultrathin sections (70 nm) were cut onto
Formvar/carbon coated grids. Immuno-labeling was performed by
ﬂoating grids on droplets of 0.1 M NaH2PO4 buffer containing 5% BSA
(PB-BSA), then incubating with rabbit polyclonal anti-KCa2.2 (anti-SK2,
Alomone Labs) diluted 1:50 for 90 min, or with the positive control mi-
tochondrial marker, cytochrome c oxidase (anti-COX1: Complex IV,
subunit 1) mouse monoclonal antibody diluted 1:500. Non-immune
rabbit polyclonal serum was used as the negative control. This step
was followed by 3×5 minwashes in PB-BSA. The sectionswere then in-
cubatedwith goat anti-rabbit IgG, or goat anti-mouse IgG, conjugated to
10 nMcolloidal gold [46] for 90 min at room temperature, rinsed in dis-
tilled water, and then stained with 2% aqueous uranyl acetate. Sections
were examined in a JEOL JEM2100 TEM at 80 kV.
2.12. Puriﬁcation/identiﬁcation of SKCa channel protein by isoelectric
focusing (IEF) and Western blotting
Total mitochondrial protein, once isolated and puriﬁed as above
(Section 2.9), was partitioned by IEF and the resulting fractionswere an-
alyzed formSKCa protein.Mitochondria (1 mg)were suspended in 3 mL
electrophoresis buffer (0.1% w/v CHAPS, 0.1% w/v dodecyl maltoside, 5%
(v/v) glycerol, 10 mg dithiothreitol) and IEF was performed using the
Micro-Rotofor system (BioRad, CA) for 4 h at 400 mA constant current.
The fractions thus obtainedwere collected and analyzed for SKCa protein
byWestern blot using the anti-KCa2.2 (anti-SK2) antibody. Brieﬂy, equal
volumes of the 10 fractions obtained by IEF were suspended in Laemmli
buffer and resolved using sodium dodecyl sulfate‐polyacrylamide gel
electrophoresis (SDS-PAGE) [47], as originally described by Laemmli
[48], and transferred onto poly vinylidene diﬂuoride membranes using
Transblot System (Bio-Rad) in 50 mM tricine and 7.5 mM imidazole
transfer buffer. Membranes were blocked with 10% non fat dry milk in
tris buffered saline‐TBSt (25 mM Tris–HCl at pH 7.5, 50 mM NaCl and
0.1% Tween 20) by incubating for 1 h followed by incubation in the
anti-KCa2.2 antibody (anti-SK2) solution overnight at 4 °C. After three
washes with TBSt the membrane was incubated with an appropriate
secondary antibody conjugated to horseradish peroxidase for 3 h.
After ﬁve washes with TBSt the membrane was incubated in enhanced
chemiluminescence detection solution (ECL-Plus, GE-Amersham) and
exposed to X-ray ﬁlm for autoradiography. The protein fraction
containing the largest amount of SKCa was used for single channel
recordings.
2.13. Enriching and incorporating mSKCa channel protein into lipid
bilayers
Channel activity of the puriﬁed and enriched mSKCa protein was
monitored by incorporating it into a planar lipid bilayer, as previously
described [49]. Brieﬂy, phospholipids were prepared by mixing
phosphatidyl-ethanolamine, phosphatidyl-serine, phosphatidyl-choline,
and cardiolipin (Avanti Polar Lipids) in a ratio of 5:4:1:0.3 (v/v). The
phospholipids were dried under N2 and re-suspended in n-decane to a
ﬁnal concentration of 25 mg/mL. The cis/trans chambers contained sym-
metrical solutions of 10 mM HEPES, 200 mM KCl and 100 μM CaCl2 at
pH 7.4. The cis chamberwas held at virtual ground and the trans chamber
was held at the command voltages. SKCa protein was added into the
cis chamber. The effect of the SKCa blocker apamin, 100 nM, on channel
activity was tested by adding it to the cis chamber in the presence of100 μM CaCl2. To test for Ca2+ dependence of the SKCa channel, [Ca2+]
was serially increased (1, 50 and 100 μM) in the cis chamber. Currents
were sampled at 5 kHz and low pass ﬁltered at 1 kHz using a voltage
clamp ampliﬁer (Axopatch 200B, Molecular Devices) connected to a dig-
itizer (DigiData 1440, Molecular Devices), and recorded in 1 min seg-
ments. The pClamp software (version 10, Molecular Devices) was used
for data acquisition and analysis. Additional analyses were conducted
using Origin 7.0 (OriginLab).
2.14. Matrix K+ measured in isolated mitochondria
Cardiac isolated mitochondria (0.5 mg protein/mL) were suspended
in respiration buffer containing 130 mM KCl, 5 mM K2HPO4, 20 mM
MOPS, 2.5 mM EGTA, 1 μM Na4P2O7, 0.1% BSA, pH 7.15 adjusted with
KOH. Buffer [Ca2+] was less than 100 nM as assessed by the ﬂuorescence
dye indo 1. Matrix K+wasmonitored during state 4 respiration (200 μM
ATP) with substrate Na-pyruvate (10 mM) in a cuvette-based spectro-
photometer (QM-8, Photon Technology International, PTI) with light
(λex 340 and 380 nm; λex 500 nm) in the presence of the ﬂuorescence
dye PBFI (1 μMpermg/mL protein, Invitrogen) [50]. PBFI, in the acetylat-
edmethyl-ester (AM) form, was added to themitochondrial preparation
and incubated at 25 °C for 20 min. After entering the matrix PBFI is
retained in the matrix after it is cleaved from the methyl-ester. During
the last pellet wash the extra-matrix residual dye was washed out.
Most experiments were conducted in the presence of 500 μM quinine
to block the mitochondrial K+/H+ exchanger (mKHE) and extrusion of
the K+ [50]. In some experiments 0.25 nM valinomycin, a K+ ionophore,
was given to verify an increase in matrix K+ inﬂux, and to be used as a
reference for the change of K+ inﬂux by DECB±its antagonist UCL1684.
3. Results
3.1. DCEB protects isolated heart against IR injury
Spontaneous heart rate averaged 242±13 beats/min before ische-
mia for all groups; this was not statistically different at 120 min reper-
fusion for all groups (data not displayed). If ventricular ﬁbrillation (VF)
occurred, it was only once within the ﬁrst 5 min of reperfusion in any
heart; all were converted to sinus rhythmwith intracoronary lidocaine.
After 5 min reperfusion all hearts remained in sinus rhythm, somewith
occasional pre-ventricular excitations. In data not displayed the inci-
dence of VF on reperfusion was CONTROL 100%, DCEB+TBAP 100%,
DCEB 76%, DCEB+TRAM 72%, DCEB+PAX 77%, and DCEB+GLIB 77%
(all nonsigniﬁcant vs. control group).
Figs. 1–4 show the marked degree of dysfunction or damage in the
untreated control group during and after global ischemia and the
beneﬁcial effects of PPC elicited by DCEB treatment before ischemia.
Developed LVP (Fig. 1A) and coronary ﬂow (Fig. 1B) were reduced
in each group after ischemia compared to before ischemia, but these
changes were much larger in the CONTROL and DCEB+TBAP groups
than in the other groups. Similarly, cardiac efﬁciency (Fig. 2A) was
lower and infarct size (Fig. 2B) was largest in the CONTROL and
DCEB+TBAP groups than in all other groups. The drug treatments be-
fore ischemia had no effects by themselves on any of the functional
variables. These ﬁgures indicate that these variables were markedly
improved on reperfusion after treatment with DCEB and that these
improvements were reversed by TBAP, but not by PAX, TRAM, or
GLIB.
There was no detectable change in NADH and FAD autoﬂuores-
cence in any group by drugs given and terminated before ischemia
(Fig. 3A,B). NADH (Fig. 3A) remained higher at the end of ischemia
and fell less during reperfusion after treatment with DCEB; this was
reversed by TBAP but not by TRAM. FAD remained lower at the end
of ischemia and rose less during reperfusion after treatment with
DCEB (Fig. 3B); this was reversed by TBAP, but not by TRAM. In
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on reperfusion after DCEB+PAX or +GLIB treatment vs. DCEB alone.
DHEﬂuorescence (O2•− formation) (Fig. 4A) and indo 1ﬂuorescence
(m[Ca2+]) (Fig. 4B) rose markedly in each group during the course of
ischemia. TBAP caused a small, but insigniﬁcant, decrease in DHE ﬂuo-
rescence before ischemia. TBAP reversed the effect of DCEB to reduce
O2•− and m[Ca2+] on reperfusion. Other experiments (not shown) did
not demonstrate detectable changes in ROS formation or m[Ca2+] on
reperfusion after DCEB+PAX, +GLIB or +TRAM treatments vs. DCEB
alone.
In companion experiments (Fig. 5A–D) the protective effects of
DCEB were abolished or antagonized by the SKCa channel antagonist
NS8593, thus demonstrating that DCEB protected via activation of
SKCa channels. DCEB‐induced maintenance of developed LVP was
completely blocked,while themaintenance of coronaryﬂowand the re-
duction of diastolic LVP and FAD oxidation by DCEB were all markedly
reversed by NS8593. NS8593 alone signiﬁcantly depressed developed
LVP when given before ischemia and tended (non signiﬁcantly) to
slightly increase coronary ﬂow, possibly indirectly due to reduced ven-
tricular compression; thus the small increase in ﬂow (Fig. 5B) noted in
the presence of DCEB is likely due to NS8593 rather than to DCEB per se.
Generally, cardiac depression before ischemia is cardioprotective, but
giving NS8593 with DCEB before ischemia, resulted in a worsening of
contractile function on reperfusion.
These studies demonstrated that DCEB had protective effects
against cardiac IR injury mediated by the SKCa channel, and that car-
diac mitochondria appeared to be involved in mediating this protec-
tion. Studies were then undertaken to isolate and identify the targetof DCEB, the SKCa protein, in cardiac isolated mitochondria and in
IMM, and to verify the functionality of the protein in an artiﬁcial
lipid bilayer.3.2. Isoelectric focusing and peptide sequences identify SKCa in isolated
IMM
IMM protein, enhanced for calmodulin-binding residues, was sep-
arated by 2-D electrophoresis after silver staining. Three peptide
spots of approximately 70 kDa at pH 5.2–5.5 were detected as SKCa
using the anti KCa2.3 (anti-hSK3) (Fig. 6, panels A–C). Complementing
this ﬁnding, a KCa2.3 protein was identiﬁed by ESI-mass spectrometry
from ﬁve matching peptides with an amino acid coverage of 10.73%
(Table 1). There was no evidence for peptides matching Na+/K+
ATPase or Ca2+ ATPase suggesting the absence of sarcolemmal and
t-tubular membranes in the mitochondrial fraction. The mass spec-
trum of one of these peptide sequences is shown (Fig. 7). These re-
sults demonstrated that SKCa channels were present in the IMM.3.3. Western blots of serially puriﬁed mitochondria demonstrate SKCa
channel protein
Mitochondria exhibited increasing band densities for both SKCa
and ANT protein (Fig. 8) when enriched by Percoll gradient serial
puriﬁcation. This furnished compelling Western blot evidence that
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ent only in the IMM.
3.4. Immunochemistry and confocal microscopy identify SKCa channel
protein in mitochondria
Confocal microscopy was used to localize SKCa protein to intact
mitochondria. Cardiac mitochondria were visualized as stained by an
antibody against ANT (green), and SKCa channel protein was visualized
using the anti-KCa2.2 (anti-SK2) antibody (red) (Fig. 9). Overlay of the
two images (yellow) shows co-localization of SKCa and ANT proteins
in cardiac mitochondria. Since ANT localizes only to the IMM, this
suggested that SKCa channel protein also localizes to the IMM.
3.5. Immuno-gold labeling and EM show localization of SKCa channels in
mitochondrial matrix
To further conﬁrm the presence and localization of the SKCa chan-
nels on the IMM, mitochondria were visualized at high resolution
using IEM. A large ﬁeld EM view shows largely normal appearing car-
diac mitochondria with intact outer membranes and cristae (Fig. 10).
Enhanced resolution of immuno-gold labeled mitochondria shows
gold particles attributed to SKCa channels (Fig. 11A,B) or cytochrome
c oxidase (COX) (Fig. 11C) within the matrix; in detailed examination
of electron micrographs approximately 50% contained at least 2 gold
particles. Negative controls (Fig. 11D) (non-immune rabbit polyclonal
serum) showed no gold particles in any ﬁeld. Figs. 8, 9, and 11 con-
ﬁrm that SKCa channels are located in mitochondria and most likely
in the IMM.3.6. Mitochondrial SKCa protein forms a functional channel
To test if puriﬁed mitochondrial SKCa protein forms a functional
channel, SKCa protein, isolated as noted above (Section 2.9), was incor-
porated into a planar lipid bilayer for electrophysiological measure-
ments. In the lipid bilayer, the SKCa protein exhibited robust activity in
the presence of 100 μM [Ca2+] (Fig. 12A). Two conducting states with
chord conductances of 230 and 730 pS were observed when recorded
in an ionic condition of equimolar 200 mMKCl. Adding apamin blocked
the channel activity (Fig. 12B) indicating that the functional channel
formed by themSKCa proteinwas inhibited by this SKCa channel blocker.
The mSKCa channel protein incorporated into the planar lipid bilayer
also displayed Ca2+‐dependent activity (Fig. 13). The mSKCa channel
exhibited increasing activity as [Ca2+] was serially increased from 1
to 100 μM. As shown, channel open probability (Po) increased from
Po=0.5 at 1 μM [Ca2+] to Po=1.0 at 50 and 100 μM Ca2+. A notable
observation was also the [Ca2+] dependent increase in the number of
conducting states. At 1 μM Ca2+ the predominant conductance was
180 pS; however, at 50 and 100 μMCa2+multiple, larger conductances
were revealed. Thus, as [Ca2+] was increased the mSKCa channel
exhibited greater conducting states while at lower [Ca2+], low conduc-
tance states dominated. This observation is further supported by the ex-
istence of a smaller conductance channel of 70 pS which was detected,
albeit infrequently, at 1 μM Ca2+ (Fig. 13, inset).
3.7. DCEB‐induced increased matrix [K+] is blocked by UCL1684
The consequence of opening of SKCa channels to changes in mito-
chondrial matrix [K+] was also determined. In isolated mitochondria
the SKCa channel opener DCEB increased matrix [K+] in the presence
Fig. 5. Improved (A) developed LV pressure and coronary ﬂow (B), and decreased diastolic LV pressure (C) and FAD oxidation (D), after preconditioning with DCEB. Note that 10 μM
NS8593 (a speciﬁc SKCa antagonist) abrogated these protective effects of DCEB.
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The observed inﬂux of K+ into the matrix was conﬁrmed by similar K+
inﬂux induced by the K+ ionophore valinomycin. The effect of DCEB
was blocked by UCL1684 (an SKCa blocker) but not by iberiotoxin (IBX)
(a blocker of BKCa but not SKCa channels) (Fig. 14B). The increase in
matrix K+ uptake induced by DCEB and blocked by UCL1684 (Fig. 14),
and the Ca2+ induced increases in K+ current and inhibition by apamin
in lipid bilayers (Figs. 12, 13) functionally linked DCEB's cardiac effects
to SKCa channel presence and activity in cardiac mitochondria.
4. Discussion
Our results suggest a novel role for the SKCa channel in cardiac
myocyte preconditioning, likely mediated via altered mitochondrial
function due to opening of SKCa channels located in myocyte mito-
chondrial IMM (mSKCa). Our comprehensive experimental approach
shows that the well-known SKCa (and IKCa) channel activator DCEB
preconditioned hearts and that this was fully reversible by bracketing
DCEB with the intra-matrix O2•− dismutator TBAP. Cardioprotective
effects of DCEB were attributed speciﬁcally to activation of SKCa chan-
nels and not to activation of KATP, IKCa, or BKCa channels because
NS8593, but not GLIB, TRAM, or PAX blocked its effects. DCEB increased
K+ ﬂux in isolatedmitochondria and the puriﬁed SKCa protein formed a
functional channel when incorporated into lipid bilayers. Thus mSKCachannel opening, similar to that ofmKATP andmBKCa channel opening, ap-
pears to induce PPC by an as yet unclear mechanism related to enhanced
matrix K+ entry. Moreover, mitochondrial-derived O2•− is required to ini-
tiate PPC by DCEB, because if O2•− is rapidly converted to downstream
products the protection by DCEB is lost.
Just aswe supported our evidence that the SKCa channel is speciﬁcal-
ly involved in PPC of isolated hearts, we sought to support speciﬁcally
that the mSKCa channel was associated with cardioprotection. To pro-
vide evidence that DCEB has protective effects mediated by mSKCa
channels, it was necessary to rigorously identify mSKCa protein in puri-
ﬁed mitochondria, and speciﬁcally in the IMM. To do so we utilized
Western analysis and immuno-histochemistry, confocal microscopy,
electron microscopy, and mass spectrometry of puriﬁed mitochondrial
proteins derived from IMM. Organelle location was accompanied by
channel functionality in isolated mitochondria and in lipid bilayers,
thus supporting that this channel may play a role in cardiac protection
via a mitochondrial mechanism. Overall our study indicates that the
SKCa channel, localized in the cardiac cell IMM, mediates the effect of
DCEB in preconditioning of the heart via a mitochondrial mechanism
related to mK+ ﬂux and O2•− generation.
The dequalinium analogue, UCL1684, is known to block opening
of apamin-sensitive SKCa channels in mammalian cell lines [51]. We
support involvement of themitochondrion in DCEB's PPC effect because
TBAP could block the protective functional effects of DCEB as well as
Fig. 6. Identity of small-conductance KCa channels in IMM from guinea pig heart.
Top panel: Silver staining of calmodulin afﬁnity column-puriﬁed protein fractions
after 2-D gel fractionation. The square indicates the area of interest, which was magni-
ﬁed and is shown in the middle panel. The arrows indicate position of KCa2.3 proteins.
Bottom panel: Western blot with an antibody targeting SKCa (anti-hSK3) channel
detection at 3 spots at 70 kDa (arrow) between pH 5.2 and 5.5. Negative control was
done by pre-incubating KCa2.3 antibodies with blocking peptide (not shown).
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of O2•−, presumably generated by complexes along the electron trans-
port system [52]. Also, DCEB directly induced an increase in matrix K+
uptake. Moreover, since DCEB had no signiﬁcant effects on coronary
ﬂow (Fig. 1), automaticity, or contractility, this suggests DCEB had no
effect on endothelial/vascular or ventricular cell function. Overall,
our results demonstrate the marked cardioprotective effects after
preconditioning with DCEB and implicate mSKCa channel opening and
generation of O2•−, or its products, as initiators and inhibitors of mito-
chondrial as well as cardiac myocyte PPC.
The improvement in cardiac function by DCEB was accompanied by
reduced formation of O2•−, reduced m[Ca2+], and improved redox state
(more normalNADHand FAD levels) during both ischemia and reperfu-
sion. These cardioprotective effects of DCEBwere blocked only by either
TBAP or NS8593.We suggest that initial formation of O2•− is essential for
the triggering mechanism of PPC by mSKCa channel activation. Howev-
er, a downstream product of O2•−, e.g. H2O2, might actually mediate the
protective effects of DCEB. A similar dependence for O2•− has been ob-
served for the mKATP channel opener diazoxide [24], the BKCa channel
opener NS1619 [4], and volatile anesthetics [27,34]. Drug lipophilicity
with mitochondrial membrane penetration may be an important com-
mon denominator for the activity of drugs such as diazoxide, a putative
mKATP channel agonist, and DCEB.
4.1. Distribution and function of Ca2+‐sensitive K+ channels
The cell membranes of vascular smoothmuscle, neural, and secretory
cells contain large conductance (200–300 pS) i.e. big Ca2+-sensitive K+
(BKCa, aka maxi-KCa) channels that when opened produce vasodilation,
hyperpolarization, and secretion. BKCa channel opening is activated by in-
creased [Ca2+]i and by cell membrane depolarization [53]. Activation of
BKCa over a range of [Ca2+] is mediated at several binding sites within
the channel [54] so that there is a wide range of [Ca2+] responsiveness(Ka 10–1000 μM) [55]. As K+ exits the cell with BKCa channel opening,
this elicits cell membrane repolarization or hyperpolarization, which in
turn reduces Ca2+ entry by closing voltage-dependent Ca2+ channels.
Altered redox potential in smooth muscle [56] suggested mitochondrial
involvement. Xu et al. [57] ﬁrst furnished evidence that BKCa channels
are located in cardiac mitochondria.
The membrane bound, but non-voltage-gated, KCa channels, i.e., SKCa
and IKCa [11], are gated by Ca2+ and other factors. SKCa (a.k.a. KCa2.1–2.3,
KCNN1-3‐gene symbol) channels have characteristics that largely differ
from the BKCa channels i.e. small unitary conductance (10–30 pS),
voltage independence with activation only by Ca2+ at very low Ka
(0.3 μM with steep I/V slopes), a sensitivity to apamin, heteromeric
assembly of the SKCa pore forming subunits with calmodulin (CaM), N
rather thanC terminal EF handdomain for Ca2+binding, andCa2+gating
near the K+ selectivity ﬁlter [58]. SKCas are unique in that calmodulin
forms an integral part of the channel, forming its Ca2+-sensitive subunits
[59]. In the presence of Ca2+, two calmodulin binding domains form a
dimer, which allows the channel to open [12].
Antibodies against KCa2.2 and KCa2.3 were both used for immuno-
staining and Western blot characterizations in puriﬁed mitochondria
and in the enriched IMM fraction, respectively. We found that the iden-
tiﬁed protein was positive to both sets of antibodies. Because the
sequence homology of the SKCa family of channels (KCa2.1, KCa2.2,
KCa2.3) is highly conserved [60], the commercial antibodies we used
might not have been selective enough to deﬁnitely identify the molec-
ular identity of the speciﬁc mSKCa isoform. But we did conﬁrm that
the puriﬁed mSKCa protein formed a functional channel by recording
channel activity after incorporating the protein into a planar lipid bilay-
er. The channel was inhibited by apamin, a blocker of plasmalemmal
membrane SKCa channels. However, the recorded conductance states
were higher than those reported for cell membrane SKCa channels,
which are in the range of 10–14 pS [11,58]. The underlying cause of
this discrepancy is unclear. It is possible that mSKCa channels have bio-
physical attributes that are different from their cell membrane counter-
parts. In particular, the mSKCa channels exhibited multiple conducting
states that appear to be Ca2+‐dependent. As the [Ca2+] increased, the
channel's conductance also increased. Thus, at very low [Ca2+], lower
conductances may be revealed that are closer to those reported for
the plasmalemmal SKCa channel. In support of this, in some recordings
we infrequently observed a conductance of 70 pS at 1 μM [Ca2+]. How-
ever, the mechanism that underlies this Ca2+‐dependent gating of the
mSKCa channel has yet to be delineated. Though it is premature to spec-
ulate on the structural homology between the mitochondrial and
plasmalemmal SKCa channels, based on our MS data and the Ca2+ sen-
sitivity of the mSKCa channel, the Ca2+calmodulin‐binding domain and
the S6 transmembrane region appear to be conserved. Indeed, the block
of channel activity by apamin showed that this mSKCa channel does
share a pharmacological property similar to the plasmalemmal SKCa.
However, the planar lipid bilayer experiments appear to indicate
that the apamin binding site and the Ca2+ binding site are both local-
ized to the same side of the mSKCa channel. This was an unexpected
ﬁnding because apamin has been reported to be an external pore
blocker that binds to the outer pore region of the plasmalemmal
SKCa channel [61], whereas the Ca2+ sensing region was believed to
be on the intracellular side, conferred by calmodulin that is constitu-
tively bound to the C-terminus of the channel [12]. Consequently, our
ﬁndings would imply that the position of the C-terminus in the mSKCa
channel differs from that in the plasmalemmal SKCa channel. There-
fore, based on the sidedness of the apamin effect and Ca2+ sensitivity,
together with our observed biophysical properties, themSKCa channel
may exhibit some functional and structural differences from the
plamalemmal SKCa channel. Additional experiments will be needed
to conﬁrm this possibility.
Our study represents the ﬁrst conclusive report that identiﬁes SKCa
channels in cardiac myocyte mitochondria. Their presence in the IMM
would indicate that they have an important function in ﬁne-tuning
Table 1
Protein coverage matched to an SKCa subunit 6 isoform by NP LC/SI mass spectrometry.
Reference: gi|21361129|ref|NP_002240small conductance calcium-activated potassium protein 6. Database: 
C:\Xcalibur\database\human_ref.fasta Number of Amino Acids: 736 Average MW: 82026.4 pI:10.07. (matched peptide sequences). Aka: SKCa3, KCNN3
Note the matching of peptide sequences covering subunit 6 and calmodulin binding domain.
MDTSGHFHDS GVGDLDEDPK CPCPSSGDEQ QQQQQQQQQQ QPPPPAPPAA
PQQPLGPSLQ PQPPQLQQQQ QQQQQQQQQQ QQQQQPPHPL SQLAQLQSQP 
VHPGLLHSSP TAFRAPPSSN STAILHPSSR QGSQLNLNDH LLGHSPSSTA
TSGPGGGSRH RQASPLVHRR DSNPFTEIAM SSCKYSGGVM KPLSRLSASR
RNLIEAETEG QPLQLFSPSN PPEIVISSRE DNHAHQTLLH  HPNATHNHQH
AGTTASSTTF PKANKRKNQN IGYKLGHRRA LFEKRKRLSD YALIFGMFGI
VVMVIETELS WGLYSKDSMF SLALKCLISL STIILLGLII AYHTREVQLF code:
BOLD = peptides identified
blue = transmembrane region 1
VIDNGADDWR IAMTYERILY ISLEMLVCAI HPIPGEYKFF WTARLAFSYT
PSRAEADVDI ILSIPMFLRL YLIARVMLLH SKLFTDASSR SIGALNKINF
NTRFVMKTLM TICPGTVLLV FSISLWIIAA WTVRVCERYH DQQDVTSNFL green = selectivity pore
GAMWLISITF LSIGYGDMVP HTYCGKGVCL LTGIMGAGCT ALVVAVVARK grey = transmembrane region 6
LELTKAEKHV HNFMMDTQLT KRIKNAAANV LRETWLIYKH TKLLKKIDHA yellow = calmodulin binding domain
KVRKHQRKFL QAIHQLRSVK MEQRKLSDQA NTLVDLSKMQ NVMYDLITEL (CaMD)
NDRSEDLEKQ IGSLESKLEH LTASFNSLPL LIADTLRQQQ QQLLSAIIEA
RGVSVAVGTT HTPISDSPIG VSSTSFPTPY TSSSSC
Protein Coverage: MH+ % Mass AA % AA 
RALFEKR 920.09 1.12 279 - 285 0.95 
GVCLLTGIMGAGCTALVVAVVARKLELTK 2888.59 3.52 527 - 555  3.94 
HVHNFMMDTQLTKR 1759.05 2.14 559 - 572 1.90 
IKNAAANVLRETWLIYK 2004.36 2.44 573 - 589 2.31 
FLQAIHQLRSVK 1440.72 1.76 609 - 620 1.63 
Totals: 8936.73 10.89 79 10.73 
Letters in bold represent those peptides identiﬁed based on their MS/MS proﬁles. The list below the sequence represents all peptides identiﬁed by mass spectrometry. The
gray-ﬁlled sections of the bar above the sequence represent the position of the identiﬁed peptides in the sequence. Also shown is the molecular weight and pI of the protein.
There are 4 peptides covering 10.89% of the total amino acids of this protein segment. Note that the mass spectral analysis showed a 70% amino acid coverage in the calmodulin
binding domain (CaMBD), a peptide sequence just before (N terminus) the pore forming subunit 1, and the entire sequence of subunit 6.
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trol, which is largely controlled by K+ ﬂux. In contrast, the voltage
and Ca2+-dependent BKCa channels may open only when ΔΨm is high
(state 4 respiration) or in response to a large imbalance in m[Ca2+]
or cytosolic [Ca2+], much as BKCa channels regulate cell membrane po-
tential in excitable cells.
Three genes encode the SKCa family; all have been cloned, and the
amino acid sequences predict subunits similar to those in other K+
channels. Channel speciﬁcity resides in the C terminal domains
where each SKCa subtype interacts with the ubiquitous Ca2+ sensor
CaM. This constitutive binding domain is called CaMBD [62]. Crystal
structures show that SKCa+CaMBD contains two EF hand motifs
within each of the globular N and C terminal regions separated by a
ﬂexible linker [62]. The C terminus is required to establish the link
of SKCa and CaM. Substitution of neutral amino acids for aspartate
and glutamate only in N terminus EF hand region blocks Ca2+ gating.
This binding site is positioned just below the K+ selectivity ﬁlter,
which suggests that conformational changes near or even in the se-
lectivity ﬁlter itself function to gate SKCa channels. The 18 amino
acid bee venom toxin apamin is highly selective for SK2 by docking
at the pore entrance and between the S3 and S4 loops [63].
SKCa channels in neurons lie adjacent to Ca2+ stores and Ca2+ chan-
nels. In nerve cells SKCa channels play a role in setting the intrinsic ﬁringfrequency, while BKCa channels regulate action potential shape and
may contribute to the unique climbing ﬁber response [15]. The K+
ﬂuxmediated by BKCa and SKCa channels inmitochondriamay be differ-
entiated by both their sensitivities to Ca2+ and dependence on ΔΨm
during states 3 and 4 respiration. Because there are many differences
between these channels, the functional effects of opening these chan-
nels are expected to differ; e.g., unlike BKCa, SKCa channel opening
may “ﬁne tune”matrix K+ inﬂux due to changing Ca2+ levels indepen-
dent of changes in ΔΨm during the variable rate of oxidative
phosphorylation.
4.2. mSKCa channel opening triggers preconditioning via ROS
The presence of both SKCa and BKCa channels in cardiac myocyte
IMM indicates a functional importance for these channels during ex-
cess mCa2+ loading; moreover their endogenous opening during
IPC, or as a pharmacological therapy, may be an important trigger
for cardioprotection. It is unclear if these drugs actually open these
K+ channels directly to elicit preconditioning, or if they themselves
alter mitochondrial bioenergetics (as mild uncouplers of oxidative phos-
phorylation), which mediates the memory of preconditioning by other
downstream effectors. Although the mitochondrial preconditioning
effect of DCEB appears to require both mSKCa channel opening and
Fig. 7. Identiﬁcation of one peptide, FLQAIHQLRSVK (in CaMBD), from the data obtained using nano-LC/MS. The b-ions and y-ions are fragment masses of the above peptide upon its col-
lision fragmentation. Peptideswere identiﬁed by searching the rodent subset of Uniprot databases. This proteinwas identiﬁed based on the 5matching peptide sequences shown in Table 1.
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TBAP are washed out before ischemia.
There is ample evidence that O2•− is necessary to trigger PPC by mK+
channel openers but themechanism of O2•−, and its products or reactants,
in mediating PPC is unknown. An increase in redox state (increased
NADH, decreased FAD) at a given [O2] can result in increased O2•− gener-
ation [64]. O2 derived free radical “bursts” are known to occur during re-
perfusion when excess O2 is available. Our group [4,26,27,33] and others
[35,65] have shown,moreover, that ROS are also formed in excess duringFig. 8. Western blots of serially puriﬁed mitochondria showed increasing amounts of
SKCa protein. Equal amounts of protein were loaded in the gel. Total homogenate
(lane 1, TH) showed least band intensity, followed by mitochondria isolated by differ-
ential centrifugation (lane 2 RC); mitochondria puriﬁed further by Percoll gradient
puriﬁcation (lane 3, PP) had the highest band intensity. Protein bands of SKCa are ap-
proximately 68 kDa. Purity of mitochondria was followed by assaying the increased
amount of ANT, along with SKCa, protein in their respective puriﬁcation fractions.ischemia before reperfusion when tissue O2 tension decreases, the redox
state increases and then decreases, and cytochrome c oxidase (complex
IV) activity is low [66]. The putative mKATP channel opener diazoxide
[67] mimicked IPC on reducing infarct size and the ROS scavengers,
N-acetylcysteine [68] or N-mercapto-propionyl-glycine [24], blocked
the preconditioning effect of diazoxide. It has been suggested that
mKATP channel opening can cause a small increase in ROS formation
[69], whichmay trigger cardioprotection through activation of protein ki-
nases. Conversely, ROS have also been proposed to activate the sarcolem-
mal KATP channel by modulating its ATP binding sites as this effect is
blocked by GLIB or by ROS scavengers [70]. Others have proffered that
ROS produced during IPC may afford cardioprotection on reperfusion di-
rectly, or via a feed forward mechanism for KATP channel-induced ROS
production [71,72].
In the present study evidence that the protective effect of DCEB is
mediated by ROS is indicated by reversal of the protection in the pres-
ence of TBAP. O2•− or OH•, or even non-radical reactants like H2O2 or
ONOO− (formed in the absence or presence of NO•, respectively)
may actually produce the preconditioning responses, but O2•− appears
necessary to initiate the response. It is also possible that mSKCa,
mBKCa, and or mKATP channel activation is altered by ROS as a feed
forward controller of mitochondrial function. Enhanced electron trans-
fer before ischemia may minimize respiratory inefﬁciency, i.e., reduced
matrix contraction and improved respiration on reperfusion. mSKCa
channel opening, like mKATP channel opening, and indeed opening of
any mK+ channel, could induce PPC by mildly enhancing O2•− genera-
tion, which stimulates enzymatic pathways that help to protect the
Fig. 9. SKCa protein identiﬁed in isolated mitochondria and visualized by confocal mi-
croscopy. Overlay of the two images (anti-ANT, green and anti-SKCa, red) demonstrates
co-localization (yellow) of the SKCa protein in mitochondria.
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TBAP blocked protection by DCEB.
When DCEB was given alone or with any of the inhibitors, it had
no direct detectable effect on mechanical function or mitochondrial
bioenergetics (redox state, O2•− levels) in isolated hearts. In our relat-
ed study [4] neither NS1619 nor its antagonist PAX showed any direct
effect on measured variables. In the ex vivo, intact heart perfusedFig. 10. Electron micrograph of isolated mitochondria. Larger ﬁeld view of untreated
mitochondria shows largely intact structural characteristics after isolation from guinea
pig hearts.with adequate substrates and O2, mitochondria are mostly respiring
in the non-resting state 3, so small changes in O2•− between states 3
(ample ADP) and 4 (consumed ADP) respiration cannot be observed.
However, in isolated cardiac mitochondria we reported that low,
but not high, concentrations of the BKCa channel opener NS1619 can
increase resting state 4 respiration and ROS generation while
maintaining IMM potential (ΔΨm) [6].
We propose similarly that DCEB, like NS1619, increases intramatrix
K+, which is replaced immediately withH+ via KHE.We suggest that at
low concentrations of these openers a transient increase in matrix acid-
ity, i.e., via a proton leak, stimulates respiration but maintains ΔΨm so
that a greater amount of O2•− is generated at mitochondrial respiratory
complexes due to impaired electron transport. O2•− itself, or a reactant,
may in turn stimulate downstream-induced phosphorylation pathways
fostering K+ channel opening as necessary when ischemia occurs. The
net effect could be preservation of mitochondrial bioenergetics during
ischemia as evidenced by better maintenance of the reduced state
(high NADH and low FAD) and smaller increases in O2•− generation
and less m[Ca2+] overload. This could lead to better preservation of ox-
idative phosphorylation and ATP turnover leading to better utilization
of ATP on initial reperfusion after ischemia.
4.3. Putative mechanism of mitochondrial K+ ﬂux on mitochondrial
protection during IR injury
BKCa and SKCa channel openers appear to have a profound ability
to induce PPC but the mechanism is unclear. It is possible that brief
ischemia as in IPC causes a slight elevation of mCa2+ that induces
mSKCa and mBKCa channel opening and, like mKATP channel opening,
leads to partial dissipation of ΔΨm and or matrix swelling as a protec-
tive mechanism against subsequent IR injury. It is now clear that K+ is
required for optimal functioning of oxidative phosphorylation because
matrix K+ ﬂux largely regulates matrix volume and can modulate
ΔΨm [73–75]. Trans-matrix K+ ﬂux can also modulate ROS production
[6]. mSKCa channels, like mBKCa channels [57,76], may act to modulate
matrix volume during times of increased matrix Ca2+ load, such as oc-
curs during IR injury [25,29]. Xu et al. [57] ﬁrst suggested that opening
mBKCa channels to enhance matrix K+ inﬂux is an important factor in
mitigating IR injury in a manner similar to mKATP channels. They pro-
posed [57] that the function of mBKCa channels was to improve the ef-
ﬁciency of mitochondrial energy production.
As with the other two K+ channels reported in mitochondria, KATP
and BKCa, once the K+ channel is opened the increase in K+ uptake
leads to changes in the matrix as described by Garlid et al. and Beavis
et al. [77,78]. Electrogenic H+ efﬂux driven by the respiratory chain is
balanced by electrophoretic K+ inﬂux. If this were uncompensated, it
would cause a very large increase in matrix pH of about 2 pH units.
Partial compensation is provided by electroneutral uptake of sub-
strate anions, such as phosphate. The compensation is partial because
the concentration of phosphate in the cytosol is much lower than that
of K+, and this imbalance leads to matrix alkalinization [79,80]. Ma-
trix alkalinization now releases the K+/H+ antiporter from inhibition
by matrix protons [75], causing K+ efﬂux to increase in response to
increased K+ uptake until a new K+ steady state is achieved. An in-
crease in futile K+ cycling is believed to produce mild uncoupling
[78] and regulates mitochondrial bioenergetics and ROS emission.
AlthoughmKCa channels likely play a role in regulatingmitochondri-
al bioenergetics, it is unknown how opening of these channels leads to
more normalized NADH/FAD levels, reduces excess ROS, and decreases
Ca2+ loading during IR. Just as the existence and function of the mKCa
channel in IMM onmitochondrial respiration is unclear, so is themech-
anism of K+ inﬂux via mKATP channels in IMM [73,76,81–84]. For the
KATP channel it was proposed that its opening depolarizes the IMM
to cause uncoupling and hasten respiration [76,81,85]. Subsequent is-
chemia would then reduce the driving force for Ca2+ inﬂux through
the mCa2+ uniporter; this could attenuate mCa2+ overload [86,87] so
Fig. 11. Immuno-electron microscopy of isolated cardiac mitochondria. A, B: SKCa protein as visualized in two mitochondria; 50% of all viewed mitochondria exhibited gold labeling.
Gold labeling was obtained by immuno-gold secondary antibody conjugated to primary rabbit polyclonal anti-KCa2.2 (anti-SK2). C: Positive control was anti-cytochrome c oxidase
(COX1) conjugated to goat anti-rabbit or mouse conjugated to colloidal gold; each mitochondrion in a large ﬁeld view exhibited at least two gold particles. D: Negative control was
only secondary polyclonal rabbit antibody conjugated to gold; there was no gold labeling of any mitochondria in any views.
Fig. 12.mSKCa channel protein activity. Puriﬁed mitochondrial SKCa protein was incor-
porated into a planar lipid bilayer and channel activity was recorded at a membrane
potential of−10 mV in the presence of 100 μM CaCl2. Dotted lines denote zero current
levels and downward deﬂections denote channel openings. A: Two primary conduc-
tance states with chord conductances of 230 and 720 pS were observed under control
conditions. The current recording is also depicted in an expanded time scale. Correspond-
ing all-point amplitude histogram is also shown. B: Channel activitywas blocked by adding
100 nM apamin.
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ciently. Indeed the putativemKATP channel opener diazoxide is reported
to reduce the rate of mCa2+ uptake by depolarizing the IMM and
decreasing the driving force for mCa2+ entry [76,81,85], although this
could be due to respiratory inhibition distinct from KATP channel open-
ing [73,88].
Garlid's group [73,88], moreover, proposed that the physiological role
of potential mK+ channels is control of matrix volume rather than dissi-
pation of ΔΨm and uncoupling. They postulated that matrix swelling by
K+ uptake is caused by concomitant uptake of Cl− andwater by osmosis.
But subsequent activation ofmKHEmay only slightly dissipate the proton
gradient (ΔμH) by increasingmatrix acidity (proton leak) without signif-
icantly altering ΔΨm [74,88]. In turn, mitochondrial swelling might opti-
mize mitochondrial function because partial uncoupling was seen to
improve efﬁciency of oxidative phosphorylation [89]. More speciﬁcally,
during hypoxia matrix K+ inﬂux appears to maintain a normal matrix
volume, which preserves a narrow intermembrane space and helps to fa-
cilitate energy transfer to ATP-utilizing sites, to reduce outer membrane
permeability to nucleotides, and to slow ATP hydrolysis [73–75]. The
end result of mSKCa channel opening, like mKCa channel opening, may
be to improvemitochondrial efﬁciency, reducem[Ca2+] andROSproduc-
tion, and thereby to protect overall mitochondrial function during IR.
4.4. Interrelationship and timing of mCa2+ loading, ΔΨm, redox state,
and ROS during cardiac IR injury
Prolonged mitochondrial ischemia is marked by the following:
decreasing ΔΨm, an oxidized redox state, excess ROS, matrix contrac-
tion, and increasing mCa2+ loading. Ca2+ overload due to leaky IMM
could impede normal electron transfer so that greater amounts of
ROS are produced during IR. Alternatively, ROS can damage mem-
branes by lipid peroxidation; this can hamper selective permeability
Fig. 13.mSKCa channel sensitivity to [Ca2+]. Channel activity of puriﬁed mitochondrial SKCa protein, incorporated into the planar lipid bilayer, was recorded at a membrane poten-
tial of −10 mV. [Ca2+] was incrementally increased; dotted lines denote zero current levels and downward deﬂections denote channel openings. The corresponding all-point
amplitude histogram is also shown. The predominant conductance was 180 pS when channel activity was recorded in 1 μM [Ca2+]. However, we have also observed,
infrequently, a smaller conducting state of 70 pS at 1 μM [Ca2+]. A sample tracing is depicted in the inset in which the calibration for the x- and y-axis is 200 ms and 1 pA, respec-
tively; C and O denote the closed and open states, respectively.
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reverse mode sarcolemmal Na+/Ca2+ exchange (NCE) [90,91].
Our studies in the intact heart model show an interrelationship
between O2•− produced, redox state, and mCa2+ inﬂux during ischemia.
Continuously measured NADH and O2•− changed together during ische-
mia as well as during reperfusion. Ischemia-induced rises in NADH
[4,25,28,30,33], ROS [4,26,27,33], andm[Ca2+] [4,25,29,33] returned clos-
er to normal values on reperfusion after PPC. These effects were reversed
by ROS scavengers or by blocking sarcolemmal KATP and/or mKATP chan-
nel opening with GLIB or 5-hydroxydecanoate [27,29]. Preconditioning
also led to reduced ROS generation and improved ATP synthesis in isolat-
ed mitochondria [92]. These studies suggest that temporary exposure to
distinct cardioprotective drugs before ischemia causes ROS-dependent
changes in mitochondrial bioenergetics that initiates a preconditioning
effect. mKCa is likely to be activated endogenously as matrix Ca2+ rises
in response to an increase in Ca2+ load, such as occurs during ischemia;
opening these channels pharmacologically before ischemia may lead to
added protection.
4.5. Summary and limitations
We have furnished ample evidence for the presence of SKCa chan-
nels in puriﬁed mitochondria and in IMM from cardiac cells, for thefunctional effects of the IKCa and SKCa channel opener DCEB on K+
ﬂux in isolated mitochondria, and for the channel conductance of
SKCa proteins incorporated into planar lipid bilayers. Moreover, we
have demonstrated that SKCa channel opener DCEB initiates cardiac
PPC as shown by marked metabolic and functional improvements
during reperfusion. These are supported by better preserved reduced
redox state (high NADH and low FAD), decreased O2•− production, re-
duced mCa2+ loading during IR, and reduced infarct size. The protec-
tion by DCEB was blocked by dismutation of O2•− with TBAP and by
the SKCa antagonist NS8593. It is possible that mSKCa channel opening
induces a mild proton leak due to mKHE, which accelerates respira-
tion, but maintains ΔΨm, so that small amounts of generated O2•− trig-
ger a downstream protective pathway.
All of the K+ channel agonists may converge on a pathway that
stimulates a small amount of ROS. That TBAP blocks protection by
this drug and that mitochondria are a major source of ROS, suggest
that DCEB exerts its effects primarily in mitochondria. Only relative
changes in NADH and FAD levels and ROS formation can be assessed
in our model. We did not test if the mSKCa channel is open during
IR injury, although we have preliminary evidence that the BKCa chan-
nel is open during reperfusion [93]. It is plausible that some factors
that induce preconditioning, like small increases in ROS or m[Ca2+],
are the same factors, albeit at much greater levels, that cause IR
Fig. 14. A: Sample time tracing showing effect of 30 μM DCEB in the presence of
500 μM quinine (KHE inhibitor) to increase matrix K+ (PBFI ﬂuorescence) in mito-
chondria isolated from a guinea pig heart. No change was observed in the absence of
quinine. The DCEB-induced increase in K+ ﬂux was completely blocked by 100 nM
UCL1684. Note larger but similar effect of 1 nM valinomycin, a K+ ionophore, to DCEB.
B: Summary effects (n=10 mitochondrial preparations) of DCEB, expressed as a % of
valinomycin effect, on increasing matrix K+ in the presence of quinine. This increase in
K+ was blocked by SKCa channel blocker UCL1684 but not by 200 nM iberiotoxin (IBX),
a blocker of BKCa channels.
440 D.F. Stowe et al. / Biochimica et Biophysica Acta 1828 (2013) 427–442damage. Thus the individual stages of triggering, activation and
end-effect must be well delineated to unravel the complicated mech-
anism underlying the cardiac protection afforded by preconditioning.
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